Komori
General Meetings of Shareholders4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Partial Revision to the "Notice of Convocation of the 68th Annual General Meeting of Shareholders" (12 June)

Descriptions in 2 places in the Notice of Convocation of the 68th Annual General Meeting of Shareholders were corrected. The derivation timing was changed from March 2024 to March 2025, and the disclosure of the weighting of the representative director’s performance-linked bonus was corrected for accuracy.

Worth reading
17Immaterial
Scored from 1 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (68th)
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (68th)
Items this document does not state (5)
Date and timeMatters for resolutionShareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because there were items in the Notice of Convocation that required correction.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Partial Revision to the "Notice of Convocation of the 68th Annual General Meeting of Shareholders" (12 June) | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori